Page last updated: 2024-08-23

paclitaxel and Cystadenocarcinoma, Papillary

paclitaxel has been researched along with Cystadenocarcinoma, Papillary in 48 studies

Research

Studies (48)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	15 (31.25)	18.2507
2000's	25 (52.08)	29.6817
2010's	7 (14.58)	24.3611
2020's	1 (2.08)	2.80

Authors

Authors	Studies
Batman, S; Bohn, J; Bruegl, A; Caughey, A; Hersh, A; Weisenberger, MW; Winter, W	1
Broadwater, G; Chino, JP; Foote, J; Gaillard, S; Havrilesky, LJ; Hong, JC	1
Devi, S; Fatima, R; Jagadish, N; Kumar, V; Sharma, A; Suri, A; Suri, V	1
An, N; Gao, M; Gao, YN; Jiang, GQ; Yan, X	1
Antsaklis, A; Haidopoulos, D; Papoutsis, D; Rodolakis, A; Sotiropoulou, M	1
Bolz, K; Cheuk, R; Goh, J; Janda, M; Kondalsamy-Chennakesavan, S; Mileshkin, L; Nicklin, JL; Obermair, A; Perrin, LC; Sykes, P; Vasey, P; Wyld, D	1
Döger, FK; Küçük, M; Riza Obadaşi, A; Sezer, SD; Yüksel, H	1
Berman, ML; Dalmar, A; Lentz, SE; Mahdavi, A; Tajalli, TR; Vasilev, SA	1
Abu-Rustum, NR; Aghajanian, C; Alektiar, KM; Barakat, RR; Damast, S; Gardner, GJ; Kiess, AP; Kollmeier, MA; Makker, V	1
Cosio, S; Fuso, L; Gadducci, A; Landoni, F; Maggino, T; Sartori, E; Zola, P	1
Matsui, H; Nagai, Y; Seki, K; Sekiya, S; Suzuka, K; Tanaka, N	1
Calderisi, MD; Corona, F; De Petris, L; Di Placido, M; Longo, F; Malizia, A; Marenga, G; Mongardini, M; Patrizi, V; Priore, FM; Schillaci, F; Scirocchi, R; Stagnitti, F; Tiberi, R	1
Anderson, P; Fields, A; Goldberg, G; Guha, C; Gupta, S; Jones, J; Khabele, D; Runowicz, C; Sood, BM; Vikram, B	1
Abraham, R; Cronk, M; Perrin, L	1
Asmar, L; Bailey, CL; Gordon, AN; Messing, MJ; Pippitt, CH; Savage, J; Street, DG; Young, JA	1
Camatte, S; Castaigne, D; Dubernard, G; Duvillard, P; Fourchotte, V; Lhommé, C; Morice, P; Pautier, P; Pomel, C; Rey, A; Thoury, A	1
Gao, YN; Li, WF; Liu, JX; Tang, WS; Wang, W	1
Berman, ML; Chan, JK; Hamilton, CA; Husain, A; Kapp, DS; Liou, WS; Osann, K; Teng, NN	1
Gross, C; Krüger, U; Rompel, R; Scholz, S	1
Horowitz, NS; Krasner, CN; Lee, SI; Oliva, E; Roche, M; Supko, JG	1
Bădulescu, A; Bădulescu, F; Popescu, CF; Schenker, M; Stoica, Z	1
Carrucciu, GM; Gramignano, G; Mais, V; Mantovani, G; Melis, GB; Parodo, G	1
Wang, HJ; Zheng, WX	1
Einstein, MH; Fields, AL; Gebb, J; Goldberg, GL; Novetsky, AP	1
Abacioglu, U; Abdah-Bortnyak, R; Amit, A; Atahan, IL; Azria, D; Gold, DG; Goldberg, H; Kuten, A; Lavie, O; Meirovitz, A; Miller, RC; Ozsahin, M; Poortmans, PM; Steiner, M; Villà, S; Yildiz, F; Zidan, J	1
Furukawa, N; Haruta, S; Kanayama, S; Kawaguchi, R; Kitanaka, T; Kobayashi, H; Naruse, K; Oi, H; Sado, T; Sakata, M; Yamada, Y; Yoshida, S	1
Abushahin, F; Belinson, J; Fader, AN; Gibbons, H; Markman, M; Rose, P; Starks, D; von Gruenigen, V	1
Fang, SH; Gao, YL; Yu, AJ	1
Donner, LR; Kavanagh, JJ; Kudelka, AP; Mante, R; Silva, E; Wilailak, S	1
Jenkins, JJ; Mandrell, BN; Pratt, CB; Smiley, LM; Wall, JE	1
Resnik, E; Taxy, JB	1
Balat, O; Edwards, CL; Kavanagh, JJ; Kudelka, AP; Tunca, JC; Verschraegen, C	1
Goldberg, JM; Hempling, RE; Piver, MS; Recio, FO	1
Fennelly, D; Gogas, H	1
Aghajanian, C; Fennelly, D; McKenzie, M; Norton, L; O'Connor, C; O'Flaherty, C; Shapiro, F; Spriggs, D; Tong, W	1
Edwards, CL; Herrada, J; Kavanagh, JJ; Kudelka, AP; Shin, DM; Tornos, C; Verschraegen, CF	1
Belinson, J; Hurteau, J; Kennedy, A; Kulp, B; Markman, M; Peterson, G; Sutton, G; Webster, K	1
Belinson, JL; Kennedy, AW; Kulp, B; Markman, M; Peterson, G; Rybicki, LA; Webster, KD	1
Benjapibal, M; Edwards, CL; Kavanagh, JJ; Kudelka, AP; Vadhan-Raj, S; Valero, V; Vasuratna, A; Verschraegen, CF	1
Cohen, Y; Horowitz, J; Meirovitz, M; Piura, B	1
DiSaia, PJ; Le, TD; Rutgers, JL; Yamada, SD	1
Belinson, JL; Kennedy, AW; Markman, M; Webster, KD; Zanotti, KM	1
Eltabbakh, GH; Garafano, LL; Hammond, JM; Moody, J	1
Markman, M	1
Aoki, Y; Kazama, JJ; Kurata, H; Tanaka, K; Tomita, M	1
Bevers, M; Bodurka-Bevers, D; Burke, TW; Gershenson, DM; Levenback, C; Ramondetta, L	1
Kairi-Vasilatou, E; Koutselini, HA; Lazaris, AC; Papayannopoulou, A; Thomopoulou, G	1
Fujiyoshi, K; Harada, C; Ishimatsu, J; Kamura, T; Kawagoe, H; Kawata, T; Nishio, S; Sugiyama, T; Tsunawaki, A	1

Reviews

3 review(s) available for paclitaxel and Cystadenocarcinoma, Papillary

Article	Year
Use of chemotherapy for ovarian cancer during human pregnancy: case report and literature review. European journal of obstetrics, gynecology, and reproductive biology, 2007, Volume: 131, Issue:2 Topics: Adult; Antineoplastic Agents, Phytogenic; Cystadenocarcinoma, Papillary; Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, First	2007
[Precursor lesions of type II endometrial cancer: diagnostic criteria and pathogenesis]. Zhonghua bing li xue za zhi = Chinese journal of pathology, 2007, Volume: 36, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma in Situ; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Disease Progression; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Paclitaxel; Precancerous Conditions; Radiotherapy, Adjuvant; Uterine Neoplasms	2007
Avascular necrosis following extensive chemotherapy and dexamethasone treatment in a patient with advanced ovarian cancer: case report and review of the literature. Gynecologic oncology, 1996, Volume: 63, Issue:3 Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Papillary; Dexamethasone; Etoposide; Female; Humans; Middle Aged; Neoplasm, Residual; Osteonecrosis; Ovarian Neoplasms; Paclitaxel	1996

Trials

6 trial(s) available for paclitaxel and Cystadenocarcinoma, Papillary

Article	Year
Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma. Gynecologic oncology, 2011, Volume: 120, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Female; Humans; Middle Aged; Paclitaxel; Prospective Studies; Quality of Life; Survival Analysis; Uterine Neoplasms	2011
Phase II study of sequential doublets: topotecan and carboplatin, followed by paclitaxel and carboplatin, in patients with newly diagnosed advanced ovarian cancer. Gynecologic oncology, 2004, Volume: 94, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carboplatin; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Topotecan	2004
Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC). Gynecologic oncology, 2008, Volume: 108, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Pilot Projects; Prospective Studies; Uterine Neoplasms	2008
Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:1 Topics: Adenocarcinoma, Clear Cell; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Endometrioid; Cystadenocarcinoma, Mucinous; Cystadenocarcinoma, Papillary; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel	1997
Phase 2 trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent. Gynecologic oncology, 1998, Volume: 70, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carboplatin; Cisplatin; Cystadenocarcinoma, Papillary; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms	1998
Treatment of uterine papillary serous carcinoma with paclitaxel. Gynecologic oncology, 2001, Volume: 82, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Cystadenocarcinoma, Papillary; Female; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Survival Rate; Uterine Neoplasms	2001

Other Studies

39 other study(ies) available for paclitaxel and Cystadenocarcinoma, Papillary

Article	Year
Trastuzumab with carboplatin/paclitaxel for treatment of advanced stage and recurrent uterine papillary serous carcinoma: A cost-effectiveness analysis. Gynecologic oncology, 2021, Volume: 160, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cost-Benefit Analysis; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Female; Humans; Markov Chains; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Quality-Adjusted Life Years; Receptor, ErbB-2; Trastuzumab; United States; Uterine Neoplasms	2021
Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2017, Volume: 27, Issue:4 Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemoradiotherapy; Chemotherapy, Adjuvant; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Female; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasm Staging; Paclitaxel; United States; Uterine Neoplasms	2017
Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2018, Volume: 40, Issue:5 Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenocarcinoma, Papillary; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Drug Synergism; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Injections, Intralesional; Mice, Nude; Molecular Targeted Therapy; Neoplasm Proteins; Ovarian Neoplasms; Paclitaxel; RNA Interference; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays	2018
[Impact of neoadjuvant chemotherapy on the survival of patients with stage IIIc and IV epithelial ovarian cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Papillary; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Survival Rate; Taxoids	2008
Peritoneal implantations of papillary serous ovarian cystadenocarcinoma 13 days after initial laparoscopic treatment for a presumed benign ovarian cyst. European journal of gynaecological oncology, 2009, Volume: 30, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Female; Frozen Sections; Humans; Laparoscopy; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Young Adult	2009
Papillary serous adenocarcinoma of the uterine cervix: a case report. European journal of gynaecological oncology, 2011, Volume: 32, Issue:2 Topics: Aged; Antineoplastic Agents; Carboplatin; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Fatal Outcome; Female; Humans; Hysterectomy; Paclitaxel; Uterine Cervical Neoplasms	2011
Role of adjuvant chemotherapy in patients with early stage uterine papillary serous cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2011, Volume: 21, Issue:8 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; California; Carboplatin; Chemotherapy, Adjuvant; Cystadenocarcinoma, Papillary; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Uterine Neoplasms	2011
Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer. Gynecologic oncology, 2012, Volume: 127, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemoradiotherapy, Adjuvant; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Drug Administration Schedule; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoplasm Staging; Ovariectomy; Paclitaxel; Retrospective Studies; Salpingectomy; Survival Analysis; Treatment Outcome	2012
Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2012, Volume: 22, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Doxorubicin; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Postoperative Complications; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Treatment Failure; Uterine Neoplasms; Young Adult	2012
Impact of maintenance chemotherapy on disease-free survival in patients with stage Ic and II epithelial ovarian cancer. European journal of gynaecological oncology, 2002, Volume: 23, Issue:4 Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma, Papillary; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Japan; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Retrospective Studies	2002
[Peritoneal papillary serous carcinoma: clinical report]. Il Giornale di chirurgia, 2002, Volume: 23, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cystadenocarcinoma, Papillary; Fatal Outcome; Female; Humans; Paclitaxel; Peritoneal Neoplasms	2002
Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma. International journal of radiation oncology, biology, physics, 2003, Sep-01, Volume: 57, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystadenocarcinoma, Papillary; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Retrospective Studies; Shiga Toxins; Survival Analysis; Treatment Failure; Uterine Neoplasms	2003
Case report of a generalized seizure related to Paclitaxel infusion. Journal of the National Cancer Institute, 2004, Mar-17, Volume: 96, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Cystadenocarcinoma, Papillary; Female; Humans; Infusions, Intravenous; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Seizures	2004
Prognosis of stage III or IV primary peritoneal serous papillary carcinoma. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2004, Volume: 30, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Female; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Statistics, Nonparametric; Survival Rate; Treatment Outcome	2004
[Comparison of primary extraovarian peritoneal serous papillary carcinoma with stage III-IV ovarian papillary serous carcinoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2005, Volume: 27, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma, Papillary; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Retrospective Studies; Taxoids	2005
Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma. International journal of radiation oncology, biology, physics, 2005, Nov-01, Volume: 63, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cystadenocarcinoma, Papillary; Doxorubicin; Endometrial Neoplasms; Female; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Radiotherapy, Adjuvant; Regression Analysis; Survival Rate	2005
[Erosive verrucous skin lesion on the umbilicus of a 83 year old woman]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2005, Volume: 3, Issue:1 Topics: Adnexa Uteri; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Chemotherapy, Adjuvant; Cystadenocarcinoma, Papillary; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Hysterectomy; Immunohistochemistry; Lymph Node Excision; Neoplasm Staging; Ovarian Neoplasms; Ovary; Paclitaxel; Skin; Skin Neoplasms; Time Factors; Umbilicus	2005
Case records of the Massachusetts General Hospital. Case 11-2006. A 54-year-old woman with a mass in the pelvis. The New England journal of medicine, 2006, Apr-13, Volume: 354, Issue:15 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystadenocarcinoma, Papillary; Diagnosis, Differential; Fallopian Tube Neoplasms; Fallopian Tubes; Female; Humans; Infusions, Parenteral; Middle Aged; Neoplasm Staging; Paclitaxel; Tomography, X-Ray Computed	2006
The value of serum and tissular expression of CA 125 antigen, in evaluation of the response to second line chemotherapy for the relapsed ovarian carcinoma. Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2005, Volume: 46, Issue:4 Topics: CA-125 Antigen; Cystadenocarcinoma, Mucinous; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Platinum Compounds; Topotecan; Treatment Outcome	2005
Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN). Gynecologic oncology, 2008, Volume: 108, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Disease-Free Survival; Doxorubicin; Female; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Retrospective Studies; Treatment Outcome; Uterine Neoplasms	2008
Peritoneal disseminated recurrence and lung metastasis after surgery for stage IA uterine papillary serous carcinoma of the endometrium: a case report. Archives of gynecology and obstetrics, 2008, Volume: 278, Issue:3 Topics: Antineoplastic Agents; Carboplatin; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Humans; Lung Neoplasms; Middle Aged; Paclitaxel; Peritoneal Neoplasms	2008
Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients. Gynecologic oncology, 2008, Volume: 109, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Retrospective Studies; Treatment Outcome	2008
[Analysis of therapeutic result and prognostic factor in primary fallopian tube carcinoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Papillary; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Ovariectomy; Paclitaxel; Survival Rate; Taxoids	2007
Peritoneal papillary serous carcinoma: response to Taxol in platinum resistant disease. European journal of gynaecological oncology, 1995, Volume: 16, Issue:3 Topics: Carboplatin; Cystadenocarcinoma, Papillary; Drug Resistance; Female; Humans; Middle Aged; Paclitaxel; Peritoneal Neoplasms	1995
Effectiveness of paclitaxel in treating papillary serous carcinoma of the peritoneum in an adolescent. American journal of obstetrics and gynecology, 1995, Volume: 172, Issue:3 Topics: Adolescent; Cystadenocarcinoma, Papillary; Female; Humans; Paclitaxel; Peritoneal Neoplasms; Remission Induction	1995
Neoadjuvant chemotherapy in uterine papillary serous carcinoma. Gynecologic oncology, 1996, Volume: 62, Issue:1 Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cystadenocarcinoma, Papillary; Female; Humans; Paclitaxel; Uterine Neoplasms	1996
Prolonged stabilization of progressive platinum-refractory ovarian cancer with paclitaxel: brief report. European journal of gynaecological oncology, 1996, Volume: 17, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cystadenocarcinoma, Papillary; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Ovarian Neoplasms; Paclitaxel; Platinum Compounds; Quality of Life; Salvage Therapy; Treatment Failure	1996
Paclitaxel and cisplatin combination chemotherapy in recurrent epithelial ovarian cancer. Gynecologic oncology, 1996, Volume: 63, Issue:3 Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Cisplatin; Cystadenocarcinoma, Papillary; Drug Administration Schedule; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Salvage Therapy	1996
Remission with carboplatin of paclitaxel resistant primary peritoneal papillary serous carcinoma: case report. European journal of gynaecological oncology, 1997, Volume: 18, Issue:1 Topics: Aged; Antineoplastic Agents; Carboplatin; Cystadenocarcinoma, Papillary; Drug Resistance; Female; Humans; Paclitaxel; Peritoneal Neoplasms	1997
Experience with platinum-paclitaxel chemotherapy in the initial management of papillary serous carcinoma of the peritoneum. Gynecologic oncology, 1998, Volume: 71, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carboplatin; Cisplatin; Cystadenocarcinoma, Papillary; Humans; Middle Aged; Paclitaxel; Peritoneal Neoplasms	1998
Docetaxel and cyclophosphamide induced remission in platinum and paclitaxel refractory ovarian cancer. Anti-cancer drugs, 1998, Volume: 9, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma; Cyclophosphamide; Cystadenocarcinoma, Papillary; Docetaxel; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Taxoids	1998
Dermatomyositis and peritoneal papillary serous carcinoma. European journal of obstetrics, gynecology, and reproductive biology, 1999, Volume: 82, Issue:1 Topics: Aged; Antineoplastic Agents, Phytogenic; Ascites; CA-125 Antigen; Carboplatin; Cystadenocarcinoma, Papillary; Dermatomyositis; Female; Humans; Hysterectomy; Laparoscopy; Laparotomy; Mucin-1; Paclitaxel; Peritoneal Neoplasms; Pleural Effusion	1999
Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with Taxol and carboplatin. Gynecologic oncology, 1999, Volume: 73, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cystadenocarcinoma, Papillary; Female; Humans; Neoplasm Staging; Paclitaxel; Remission Induction; Uterine Neoplasms	1999
The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma. Gynecologic oncology, 1999, Volume: 74, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carboplatin; Cisplatin; Cystadenocarcinoma, Papillary; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Survival Rate; Uterine Neoplasms	1999
The combination paclitaxel, carboplatin and megestrol acetate is effective in women with recurrent uterine papillary serous adenocarcinoma. European journal of gynaecological oncology, 1999, Volume: 20, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cystadenocarcinoma, Papillary; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Paclitaxel; Prognosis; Treatment Outcome	1999
Prolonged symptom-free survival in a patient with persistent primary peritoneal carcinoma and a rising CA-125: a note of caution. Gynecologic oncology, 2001, Volume: 81, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carboplatin; Cystadenocarcinoma, Papillary; Disease-Free Survival; Female; Humans; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Predictive Value of Tests	2001
Pharmacokinetics of paclitaxel and cisplatin in a hemodialysis patient with recurrent ovarian cancer. Anti-cancer drugs, 2001, Volume: 12, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Cisplatin; Cystadenocarcinoma, Papillary; Female; Humans; Kidney Failure, Chronic; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Ovarian Neoplasms; Paclitaxel; Renal Dialysis; Thrombocytopenia	2001
Papillary serous carcinoma of peritoneum: case study and review of the literature on the differential diagnosis of malignant peritoneal tumors. Advances in clinical pathology : the official journal of Adriatic Society of Pathology, 2001, Volume: 5, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Nucleus; Chemotherapy, Adjuvant; Cisplatin; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Diagnosis, Differential; Female; Humans; Mesothelioma; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms	2001
[A case of extraovarian primary peritoneal carcinoma successfully treated with weekly paclitaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:2 Topics: Acute Kidney Injury; Aged; Antineoplastic Agents, Phytogenic; Cisplatin; Cystadenocarcinoma, Papillary; Drug Administration Schedule; Female; Humans; Paclitaxel; Peritoneal Neoplasms	2002